Yung H. Chyung
Chief Medical Officer · Keros Therapeutics, Inc.
Individual
- 2024
- Nov 12, 2024
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Yung H. Chyung files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ADAR1 Capital Management, LLC - $95.66M in KROS purchases and sales in the last 12 months
- Pontifax Management 4 G.P. (2015) Ltd. - $84.98M in KROS purchases and sales in the last 12 months
- Esther Cho - $124K in KROS purchases and sales in the last 12 months
- Jasbir Seehra - $113K in KROS purchases and sales in the last 12 months
- Lorena Raquel Lerner - $100K in KROS purchases and sales in the last 12 months
- Keith Regnante - $77K in KROS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Yung H. Chyung?
Yung H. Chyung is a corporate insider, tracked as Chief Medical Officer of Keros Therapeutics, Inc. (KROS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Yung H. Chyung last file a Form 4?
The only primary Form 4 on record is dated 12 November 2024.